These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 9100043)

  • 1. Uremia therapy in patients with end-stage renal disease and human immunodeficiency virus infection: has the outcome changed in the 1990s?
    Ifudu O; Mayers JD; Matthew JJ; Macey LJ; Brezsnyak W; Reydel C; McClendon E; Surgrue T; Rao TK; Friedman EA
    Am J Kidney Dis; 1997 Apr; 29(4):549-52. PubMed ID: 9100043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severity of AIDS and the response to EPO in uremia.
    Ifudu O; Matthew JJ; Mayers JD; Macey LJ; Brezsnyak W; Reydel C; McClendon E; Surgrue T; Rao S; Friedman EA
    Am J Kidney Dis; 1997 Jul; 30(1):28-35. PubMed ID: 9214398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maintenance hemodialysis in patients with HIV-associated nephropathy.
    Dave MB; Shabih K; Blum S
    Clin Nephrol; 1998 Dec; 50(6):367-74. PubMed ID: 9877110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prevalence of HIV infection in dialysis patients: results of a national multicenter study].
    Poignet JL; Desassis JF; Chanton N; Litchinko MB; Zins B; Kolko A; Patte R; Sobel A
    Nephrologie; 1999; 20(3):159-63. PubMed ID: 10418006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy of erythropoietin in human immunodeficiency virus-infected end-stage renal disease patients treated by maintenance hemodialysis.
    Shrivastava D; Rao TK; Sinert R; Khurana E; Lundin AP; Friedman EA
    Am J Kidney Dis; 1995 Jun; 25(6):904-9. PubMed ID: 7771487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The intensity of hemodialysis and the response to erythropoietin in patients with end-stage renal disease.
    Ifudu O; Feldman J; Friedman EA
    N Engl J Med; 1996 Feb; 334(7):420-5. PubMed ID: 8552143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative contributions of body iron status and uremia severity to anemia in patients with advanced chronic renal failure.
    Ifudu O; Dawood M; Friedman EA
    Nephron; 1997; 77(3):315-8. PubMed ID: 9375826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Excess morbidity in patients starting uremia therapy without prior care by a nephrologist.
    Ifudu O; Dawood M; Homel P; Friedman EA
    Am J Kidney Dis; 1996 Dec; 28(6):841-5. PubMed ID: 8957035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Timing of initiation of uremia therapy and survival in patients with progressive renal disease.
    Ifudu O; Dawood M; Homel P; Friedman EA
    Am J Nephrol; 1998; 18(3):193-8. PubMed ID: 9627034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The types of renal disease in the acquired immunodeficiency syndrome.
    Rao TK; Friedman EA; Nicastri AD
    N Engl J Med; 1987 Apr; 316(17):1062-8. PubMed ID: 3561458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between urea reduction ratio, demographic characteristics, and body weight for patients in the 1996 National ESRD Core Indicators Project.
    Frankenfield DL; McClellan WM; Helgerson SD; Lowrie EG; Rocco MV; Owen WF
    Am J Kidney Dis; 1999 Mar; 33(3):584-91. PubMed ID: 10070924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is dialysis modality a factor in survival of patients with ESRD and HIV-associated nephropathy?
    Ahuja TS; Collinge N; Grady J; Khan S
    Am J Kidney Dis; 2003 May; 41(5):1060-4. PubMed ID: 12722041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human immunodeficiency virus infection in end-stage renal disease patients.
    Rao TK
    Semin Dial; 2003; 16(3):233-44. PubMed ID: 12753686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The methods of therapy ESRD patients infected with the human immunodeficiency virus-HIV].
    Gozdowska J; Durlik M
    Przegl Lek; 2008; 65(2):82-6. PubMed ID: 18663906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of End-Stage Renal Disease Patients with Advanced Uremia and Acidemia.
    Rehman IU; Idrees MK; Shoukat
    J Coll Physicians Surg Pak; 2016 Jan; 26(1):31-5. PubMed ID: 26787028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous ambulatory peritoneal dialysis and survival of HIV infected patients with end-stage renal disease.
    Kimmel PL; Umana WO; Simmens SJ; Watson J; Bosch JP
    Kidney Int; 1993 Aug; 44(2):373-8. PubMed ID: 8377381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival experience of peritoneal dialysis patients with human immunodeficiency virus: a 17-year retrospective study.
    Khanna R; Tachopoulou OA; Fein PA; Chattopadhyay J; Avram MM
    Adv Perit Dial; 2005; 21():159-63. PubMed ID: 16686310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current management of anemia in adult hemodialysis patients with end-stage renal disease.
    Frankenfield DL; Johnson CA
    Am J Health Syst Pharm; 2002 Mar; 59(5):429-35. PubMed ID: 11887409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of dialysis in children with human immunodeficiency virus infection.
    Gordillo R; Kumar J; Del Rio M; Flynn JT; Woroniecki RP
    Pediatr Nephrol; 2009 Jan; 24(1):171-5. PubMed ID: 18810503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Captopril and renal survival in patients with human immunodeficiency virus nephropathy.
    Kimmel PL; Mishkin GJ; Umana WO
    Am J Kidney Dis; 1996 Aug; 28(2):202-8. PubMed ID: 8768914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.